Glenmark Launches Calcium Gluconate Injection in US
Glenmark launches Calcium Gluconate Injection USP in the US, offering a bioequivalent and therapeutically equivalent alternative to Fresenius Kabi’s reference drug.
Calcium Gluconate Injection USP | 21/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy